Neurock Pharmaceuticals Inc. — Form D

Neurock Pharmaceuticals Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-11. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-03-11
• Form: D
• Accession: 0002014918-24-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $10.0M
• Investors: 1
• Date of first sale: 2024-02-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-507160

Issuer

• Name: Neurock Pharmaceuticals Inc.
• CIK: 0002014918
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 302 CARNEGIE CENTER, SUITE 100, PRINCETON, NJ, 08540
• Phone: 908-926-3116

Officers, directors & promoters (3)

More

• CIK 2014918 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search